Limited Partners
|
Contact Us
About Us
Portfolio
Our Team
News & Events
For Entrepreneurs
Portfolio Company News
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
Aurora News
Newsletters
Events
Speaking Engagements
Portfolio Company News, 2009
December 17
Regado Biosciences, Inc. Completes $40 Million Series D Financing
December 14
Paramount to Start Online Service to Sell Movie Clips
October 29
Aldagen refiles for IPO, raises $7.3M of $10M in debt, warrant
October 27
METABOLON CLOSES ADDITIONAL FINANCING
October 23
Argos HIV Immunotherapy Offers Potential Reprieve From Antiretrovirals
October 22
Durham startup Argos reports strong results on individualized HIV drug
October 21
Argos Therapeutics Presents Positive Phase 2 Viral Load and Immune Response Data for Arcelis™ HIV Program at the AIDS Vaccine 2009 Conference
September 29
METABOLOMICS USED TO DISCOVER BIOMARKERS FOR PERIODONTAL DISEASE
September 17
Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers
September 16
METABOLOMICS USED TO IDENTIFY THE MECHANISM OF ACTION OF AN ANTI-CANCER DRUG
September 9
REGADO BIOSCIENCES ANNOUNCES FIRST PATIENT ENROLLED IN RADAR (Phase 2b) STUDY OF REG1 ANTICOAGULATION SYSTEM
August 31
REGADO BIOSCIENCES RELEASES POSITIVE PHASE 2A DATA FOR THE REVERSIBLE ANTICOAGULANT SYSTEM REG1 AT THE EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS IN BARCELONA, SPAIN
July/August
Cardioxyl Pharmaceuticals: Treating acute decompensated heart failure
August 24
REGADO BIOSCIENCES ANNOUNCES FIRST PATIENT ENROLLED IN Phase 1 STUDY OF SUBCUTANEOUSLY ADMINISTERED REG1 ANTICOAGULATION SYSTEM
August 18
METABOLON EXPERTS TO LEAD DISCUSSIONS AT INTERNATIONAL METABOLOMICS SOCIETY MEETING
August 12
METABOLOMICS AIDS IN UNDERSTANDING MECHANISMS OF COMMONLY USED DRUGS
August 11
PATENT AWARDED TO METABOLON FOR METABOLOMICS SOFTWARE
August 5
Phase III SPA OK'd for Aldagen Limb Ischemia Stem Cell Therapy
July 29
NEW RESEARCH OFFERS INSIGHT INTO METABOLOMICS METHODS
July 28
DIAGNOSTIC DEVELOPMENT EXECUTIVE JOINS METABOLON
July 21
HyperBranch receives CE Mark
July 14
Cardioxyl's Nitroxyl Donor Drug Starts Testing in Heart Failure
July 8
METABOLON AWARDED A SERIES OF METABOLOMICS METHOD PATENTS
July 6
MicroMass Communications adds new exec
June 2009
Pathways - The Metabolon Newsletter
Summer 2009
StrikeIron News
June 10
Argos Therapeutics Publishes Research on the Immunosuppressive Properties of HIV
June 2
Regado Biosciences Establishes Medical Advisory Board
May 19
StrikeIron's Enhanced Data Services Now Integrated on Salesforce.com
May 1
Argos Therapeutics sees new promise for Immunotherapeutics
April 24
Argos Therapeutics Presents Research Validating Feasibility and Safety of its
Arcelis™ Personalized Immunotherapy Platform for HIV
April 21
BIOCHEMICAL MARKERS OF EARLY-STAGE KIDNEY TOXICITY DISCOVERED
Published Research Describes Use of Global Biochemical Profiling to Identify Markers
April 20
METABOLON ANNOUNCES GRANT PROGRAM
Academic and Government Researchers Selected to Receive Metabolomic Analysis
Spring 2009
StrikeIron News
April 2
Centice Corporation Partners with Medi-Span
Centice and Medi-Span® to present new interface for PASS Rx® at APhA
March 20
StrikeIron hits the anvil with $5M in new funding
March 9
Centice Corporation Launches New Website
Site emphasizes new PASS Rx® Drug Verification Product for Pharmacies
About Us
Portfolio
Our Team
News & Events
For Entrepreneurs
©2002–2013 The Aurora Funds, Inc.